---
title: "Regencell Bioscience Holdings Limited (RGC.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RGC.US.md"
symbol: "RGC.US"
name: "Regencell Bioscience Holdings Limited"
industry: "Pharmaceuticals"
datetime: "2026-05-20T14:03:53.421Z"
locales:
  - [en](https://longbridge.com/en/quote/RGC.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RGC.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RGC.US.md)
---

# Regencell Bioscience Holdings Limited (RGC.US)

## Company Overview

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.regencellbioscience.com](https://www.regencellbioscience.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1894.17 | 230 | - | - | - |
| PB | 10949.14 | 196 | 2887.41 | 1421.90 | 1056.67 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/RGC.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/RGC.US/norm.md)
- [Related News](https://longbridge.com/en/quote/RGC.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/RGC.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**